Search results for "Asymptomatic Diseases"

showing 10 items of 32 documents

Soft tissue pathosis associated with asymptomatic impacted lower third molars

2010

Objective: The aim of this study was to identify the prevalence of pathological changes in the pericoronal tissue of asymptomatic impacted lower third molars and to assess the correlation between pathological changes and patient demographic, radiographic and morphological characteristics. Study Design: Follicles associated with fully impacted lower third molars were submitted for histological examiDesign: Follicles associated with fully impacted lower third molars were submitted for histological examiesign: Follicles associated with fully impacted lower third molars were submitted for histological examination after surgical extraction from 50 patients. The correlation between pathological c…

AdultMaleMolarAdolescentRadiographyDentistryMandibleAsymptomaticYoung Adultstomatognathic systemPrevalenceHumansMedicineskin and connective tissue diseasesGeneral DentistryPathologicalDental folliclebusiness.industryImpactionIncidence (epidemiology)Tooth ImpactedSoft tissueMiddle Aged:CIENCIAS MÉDICAS [UNESCO]stomatognathic diseasesOtorhinolaryngologyAsymptomatic DiseasesGingival DiseasesUNESCO::CIENCIAS MÉDICASFemaleMolar ThirdSurgerysense organsmedicine.symptombusiness
researchProduct

Posterior interosseous nerve of the elbow at the arcade of Frohse: Ultrasound appearance in asymptomatic subjects

2019

PURPOSE To assess the normal values of the antero-posterior (AP) diameter of the posterior interosseous nerve (PIN) of the elbow as it passes beneath the arcade of Frohse and to search for PIN-diameter differences between the upstream, entry point and downstream of the arcade. MATERIAL AND METHODS Thirty asymptomatic patients prospectively underwent bilateral B-mode ultrasound of the PIN of the elbow. There were 15 men and 15 women with a mean age of 30.2±5.31 (SD) years (range: 26-43 years). Of these, 23 patients were right-handers (23/30; 77%) and 7 were left handers (7/30; 23%). AP diameter of the PIN was measured in long axis at three different locations including the entry point of the…

AdultMale[SDV]Life Sciences [q-bio]ElbowNormal valuesAsymptomatic030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineElbowmedicineHumansSupinator muscleRadiology Nuclear Medicine and imagingProspective StudiesUltrasonographyLeft handedRadiological and Ultrasound Technologybusiness.industryNerve Compression SyndromesUltrasoundPeripheral Nervous System DiseasesMean ageGeneral MedicineAnatomyPosterior interosseous nervemedicine.anatomical_structure030220 oncology & carcinogenesisAsymptomatic DiseasesFemaleRadial Nervemedicine.symptombusiness
researchProduct

Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies very early cardiac involvement in systemic scler…

2017

Objective To evaluate occult cardiac involvement in asymptomatic systemic sclerosis (SSc) patients by pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance (CMR), for a very early identification of patients at higher risk of cardiac-related mortality. Methods Sixteen consecutive patients with definite SSc, fulfilling the American College of Rheumatology/European League Against Rheumatism 2013 classification criteria in less than 1 year from the onset of Raynaud's phenomenon, underwent pharmacological stress, rest perfusion and delayed enhancement CMR. At enrollment, no patient showed signs and/or symptoms suggestive for cardiac involvement. No patient sho…

AdultMalemedicine.medical_specialtyAdenosineHeart diseaseHeart DiseasesVasodilator AgentsContrast MediaMagnetic Resonance Imaging CineAsymptomaticCardiac magnetic resonance imaging with pharmacological stress; Myocardial perfusion defect; Systemic sclerosis; Systemic sclerosis heart involvement; Rheumatology030218 nuclear medicine & medical imaging03 medical and health sciencesMyocardial perfusion imagingCoronary circulation0302 clinical medicineRheumatologyPredictive Value of TestsInternal medicineCoronary CirculationCardiac magnetic resonance imaging with pharmacological stressMultidetector Computed TomographymedicineHumans030203 arthritis & rheumatologyScleroderma Systemicmedicine.diagnostic_testbusiness.industryMicrocirculationMyocardial Perfusion Imagingmedicine.diseaseRheumatologymyocardial perfusion defectSettore MED/16 - Reumatologiamedicine.anatomical_structureEarly DiagnosisVentriclecardiac magnetic resonance imaging with pharmacological streAsymptomatic Diseasessystemic sclerosis heart involvementSystemic sclerosisFemaleRadiologymedicine.symptombusinessPerfusionsystemic sclerosiRheumatism
researchProduct

Should we look for silent pulmonary embolism in patients with deep venous thrombosis?

2014

Background Asymptomatic or silent pulmonary embolism (S-PE) in patients with deep vein thrombosis has been the focus of numerous publications with the objective of determining the incidence of S-PE and assessing whether its existence has any clinical or therapeutic consequences that outweigh the risks associated with the diagnostic tests performed and the increased healthcare costs. The objectives were to assess the incidence of S-PE using computed tomography angiogram (CTA), to understand the epidemiological factors that might trigger embolism, and to assess whether D-dimer (DD) predicts the existence of S-PE’s. Methods A prospective and consecutive assessment of 103 hospitalized patients …

AdultMalemedicine.medical_specialtyAdolescentDeep veinAsymptomaticFibrin Fibrinogen Degradation ProductsYoung AdultDeep vein thrombosisHumansMedicineProspective StudiesProspective cohort studyAgedAngiologyAged 80 and overVenous Thrombosisbusiness.industryIncidencePulmonary embolismMiddle Agedmedicine.diseaseThrombosisPulmonary embolismRadiographyVenous thrombosismedicine.anatomical_structureEmbolismD-dimerAsymptomatic DiseasesFemaleRadiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesResearch ArticleBMC Cardiovascular Disorders
researchProduct

Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myelo…

2011

The rate of asymptomatic amyloidosis (AL) among patients with newly diagnosed multiple myeloma (MM) or smoldering multiple myeloma (SMM) is unknown. We evaluated number and clinical significance of asymptomatic AL in consecutive MM and SMM patients, not having recognition of symptomatic AL at the time of their diagnostic bone marrow biopsy. Bone marrow biopsies were stained with Congo red and considered diagnostic for AL in case of positive Congo red staining with apple-green birefringence. Biopsies from 144 patients were evaluated: 77 had a diagnosis of MM and 67 of SMM. The median age was 59 (range 26–84) years; the median follow-up was 76 months (range 0–216). Immunoglobulin isotypes wer…

AdultMalemedicine.medical_specialtyPathologyBiopsyImmunoglobulin DAsymptomaticSettore MED/15 - Malattie Del SangueImmunoglobulin Light-chain AmyloidosisBone MarrowInternal medicineBiopsyMedicineHumansAge of OnsetMultiple myelomaAgedRetrospective StudiesAged 80 and overHematologybiologymedicine.diagnostic_testbusiness.industryAmyloidosisamyloidosis multiple myelomaHematologyGeneral MedicineAmyloidosisMiddle Agedmedicine.diseasemultiple myelomamedicine.anatomical_structureAsymptomatic Diseasesbiology.proteinFemaleImmunoglobulin Light ChainsBone marrowmedicine.symptombusiness
researchProduct

Association of MR-proadrenomedullin with cardiovascular risk factors and subclinical cardiovascular disease.

2012

Abstract Aims and background Midregional proadrenomedullin (MR-proADM) is a protein, which exerts various effects on the cardiovascular system. Recent studies underscored its prognostic implications in patients with acute dyspnea and cardiovascular diseases. Therefore, we aimed to determine the distribution of MR-proADM in the general population and to reveal potential associations of MR-proADM with cardiovascular risk factors and measures of subclinical cardiovascular disease. Methods and results MR-proADM plasma concentrations were determined in individuals of the population-based cohort of the Gutenberg Health Study ( N  = 5000) using a commercially available fluoroimmunoassay. Individua…

AdultMalemedicine.medical_specialtyPopulationFluoroimmunoassayRisk AssessmentCoronary artery diseaseAdrenomedullinSex FactorsPredictive Value of TestsRisk FactorsInternal medicineGermanymedicinePrevalenceHumansMyocardial infarctionProspective StudiesProtein PrecursorseducationSubclinical infectionAgededucation.field_of_studybusiness.industryAge FactorsMiddle Agedmedicine.diseasePrognosisPeptide FragmentsUp-RegulationCross-Sectional StudiesPhenotypeIntima-media thicknessCardiovascular DiseasesEchocardiographyHeart failureAsymptomatic DiseasesCardiologyLinear ModelsPopulation studyFemaleCardiology and Cardiovascular MedicinebusinessHeart failure with preserved ejection fractionBiomarkersAtherosclerosis
researchProduct

The size of juxtaluminal hypoechoic area in ultrasound images of asymptomatic carotid plaques predicts the occurrence of stroke

2013

Abstract OBJECTIVE: To test the hypothesis that the size of a juxtaluminal black (hypoechoic) area (JBA) in ultrasound images of asymptomatic carotid artery plaques predicts future ipsilateral ischemic stroke. METHODS: A JBA was defined as an area of pixels with a grayscale value 10 mm(2) (P 8 mm(2)) was still significant after adjusting for other plaque features known to be associated with increased risk, including stenosis, grayscale median, presence of discrete white areas without acoustic shadowing indicating neovascularization, plaque area, and history of contralateral TIA or stroke. Plaque area and grayscale median were not significant. Using the significant variables (stenosis, discr…

Asymptomatic carotid plaqueMaleTime Factorsmedicine.medical_treatmentCarotid endarterectomyKaplan-Meier EstimateSeverity of Illness Indexasymptomatic carotid artery stenosis; hypoecoic area; StrokeRisk FactorsCarotid StenosisUltrasonography Doppler ColorProspective cohort studyStrokeAged 80 and overNeovascularization Pathologichypoecoic areaMiddle AgedPrognosisPlaque AtheroscleroticEuropeStrokeIschemic Attack TransientPredictive value of testsFemaleRadiologymedicine.symptomjuxtaluminal hypoechoic area ultrasound images asymptomatic carotid plaques strokeCardiology and Cardiovascular MedicineCarotid Artery InternalAdultmedicine.medical_specialtyAsymptomaticRisk AssessmentAsymptomatic carotid plaque; Brain ischemia; Stroke; EchographyBrain ischemiaPredictive Value of Testsasymptomatic carotid artery stenosimedicineHumanscardiovascular diseasesAgedProportional Hazards Modelsbusiness.industryProportional hazards modelmedicine.diseaseAcoustic shadowSettore MED/11 - Malattie Dell'Apparato CardiovascolareStenosisROC CurveAsymptomatic DiseasesLinear ModelsSurgeryasymptomatic carotid artery stenosisEchographybusinessFollow-Up Studies
researchProduct

Early subclinical ventricular dysfunction in patients with insulin resistance

2014

AIMS: The aim of our study was to evaluate the relationship between insulin resistance and the detection of precocious echocardiographic signs of heart failure in patients with cardiovascular risk factors. METHODS: We enrolled 34 consecutive patients with cardiovascular risk factors. All patients underwent coronary angiography, echocardiography, and laboratory tests. Exclusion criteria were diabetes (fasting glucose greater than 126 mg/dl or treatment with insulin or oral hypoglycemic agents), coronary artery disease, creatinine above 1.5 mg/dl, left-ventricular hypertrophy, valvular heart disease, ejection fraction below 50%, atrial fibrillation, or other severe arrhythmia. The presence of…

Blood GlucoseMalemedicine.medical_specialtymedicine.medical_treatmentDiastolePilot ProjectsRisk AssessmentVentricular Function LeftCoronary artery diseaseVentricular Dysfunction LeftInsulin resistancePredictive Value of TestsRisk FactorsDiabetes mellitusInternal medicinemedicineHumansInsulinVentricular dysfunctionAgedUltrasonographyHeart FailureEjection fractionbusiness.industryInsulinAtrial fibrillationGeneral MedicineMiddle Agedmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareLogistic ModelsHeart failureAsymptomatic DiseasesMultivariate AnalysisCardiologyFemaleInsulin ResistanceCardiology and Cardiovascular MedicinebusinessBiomarkersJournal of Cardiovascular Medicine
researchProduct

Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier?

2018

Abstract Cardiovascular disease (CVD) is the most significant prognostic factor in individuals with type 2 diabetes (T2D). However, a significant number of individuals may develop CVD that does not present with the classic angina-related or heart failure symptoms. In these cases, CVD may seem to be ‘silent’ or ‘asymptomatic’, but may be more accurately characterised as unrecognised diabetic cardiac impairment. An initial step to raise awareness of unrecognised CVD in individuals with T2D would be to reach a consensus regarding the terminology used to describe this phenomenon. By standardising the terminologies, and agreeing on the implementation of an efficient screening program, it is anti…

Blood Glucoselcsh:Diseases of the circulatory (Cardiovascular) systemEndocrinology Diabetes and Metabolism10265 Clinic for Endocrinology and DiabetologyDiseaseType 2 diabetes030204 cardiovascular system & hematologySilent0302 clinical medicineRisk FactorsMass ScreeningAsymptomatic ; Atypical ; Cardiovascular disease ; Screening ; Silent ; Type 2 diabetes ; Unrecognised.Type 2 diabetesCardiovascular diseasePrognosisAsymptomatic3. Good health2712 Endocrinology Diabetes and MetabolismCardiovascular DiseasesScreeningmedicine.symptomCardiology and Cardiovascular Medicinemedicine.medical_specialtyPrognostic factor030209 endocrinology & metabolism610 Medicine & healthRisk AssessmentAsymptomatic2705 Cardiology and Cardiovascular Medicine03 medical and health sciencesPredictive Value of TestsInternal medicineDiabetes mellitusmedicineHumansHypoglycemic AgentsIntensive care medicineUnrecognisedbusiness.industrymedicine.diseaseEarly DiagnosisDiabetes Mellitus Type 2lcsh:RC666-7012724 Internal MedicineHeart failureAsymptomatic DiseasesCommentarybusinessAtypicalBiomarkers
researchProduct

Preclinical atherosclerosis and metabolic syndrome increase cardio- and cerebrovascular events rate: a 20-year follow up

2013

BACKGROUND: Intima-media thickness (IMT) is a validated marker of preclinical atherosclerosis and a predictor of cardiovascular events. PATIENTS: We studied a population of 529 asymptomatic patients (age 62 ± 12.8 years), divided into two groups of subjects with and without Metabolic Syndrome (MetS). METHODS: All patients, at baseline, have had a carotid ultrasound evaluation and classified in two subgroups: the first one without atherosclerotic lesions and the second one with preclinical atherosclerosis (increased IMT or asymptomatic carotid plaque). Cardiovascular endpoints were investigated in a 20-years follow-up. RESULTS: There were 242 cardiovascular events: 144 among patients with Me…

Carotid Artery DiseasesMaleAsymptomatic carotid plaqueIntima-media thicknessEndocrinology Diabetes and MetabolismMyocardial InfarctionMyocardial IschemiaMetabolic syndrome Preclinical atherosclerosis Intima-media thickness Asymptomatic carotid plaque Cardiac event Cerebrovascular eventsCarotid Intima-Media ThicknessBody Mass IndexAortic aneurysmRisk FactorsPreclinical atherosclerosisLongitudinal StudiesUltrasonography Doppler ColorOriginal InvestigationAged 80 and overMetabolic Syndromeeducation.field_of_studySmokingMiddle AgedPlaque AtheroscleroticStrokeIschemic Attack TransientHypertensionCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicineAdultmedicine.medical_specialtyCardiac eventPopulationEndarterectomyRisk AssessmentAsymptomaticAngina PectorisDiabetes mellitusInternal medicinemedicineHumansObesityeducationAgedDyslipidemiasAngiologyCerebrovascular eventsAortic Aneurysm Thoracicbusiness.industrymedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareCerebrovascular DisordersIntima-media thicknessAsymptomatic DiseasesMetabolic syndromebusinessBody mass index
researchProduct